Biblio

Export 307 results:
[ Author(Asc)] Title Type Year
Filters: First Letter Of Keyword is T  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
H. B. Allen, A Novel Approach to the Treatment and Prevention of Alzheimer's Disease Based on the Pathology and Microbiology., J Alzheimers Dis, vol. 84, no. 1, pp. 61-67, 2021.
H. B. Allen, A Novel Approach to the Treatment and Prevention of Alzheimer's Disease Based on the Pathology and Microbiology., J Alzheimers Dis, vol. 84, no. 1, pp. 61-67, 2021.
D. L. Alkon, Sun, M. - K., Tuchman, A. J., and Thompson, R. E., Advanced Alzheimer's Disease Patients Show Safe, Significant, and Persistent Benefit in 6-Month Bryostatin Trial., J Alzheimers Dis, vol. 96, no. 2, pp. 759-766, 2023.
P. S. Aisen, Andrieu, S., Sampaio, C., Carrillo, M., Khachaturian, Z. S., Dubois, B., Feldman, H. H., Petersen, R. C., Siemers, E., Doody, R. S., Hendrix, S. B., Grundman, M., Schneider, L. S., Schindler, R. J., Salmon, E., Potter, W. Z., Thomas, R. G., Salmon, D., Donohue, M., Bednar, M. M., Touchon, J., and Vellas, B., Report of the task force on designing clinical trials in early (predementia) AD., Neurology, vol. 76, no. 3, pp. 280-6, 2011.
B. Ahlemeyer, Halupczok, S., Rodenberg-Frank, E., Valerius, K. - P., and Baumgart-Vogt, E., Endogenous Murine Amyloid-β Peptide Assembles into Aggregates in the Aged C57BL/6J Mouse Suggesting These Animals as a Model to Study Pathogenesis of Amyloid-β Plaque Formation., J Alzheimers Dis, vol. 61, no. 4, pp. 1425-1450, 2018.
S. Agostini, Mancuso, R., Baglio, F., Cabinio, M., Hernis, A., Guerini, F. Rosa, Calabrese, E., Nemni, R., and Clerici, M., Lack of evidence for a role of HHV-6 in the pathogenesis of Alzheimer's disease., J Alzheimers Dis, vol. 49, no. 1, pp. 229-35, 2016.
M. Pejstrup Agger, Danielsen, E. Rubæk, Carstensen, M. Schultz, N Nguyen, M., Horning, M., Henney, M. Alexander, Jensen, C. Boe Ravn, Baandrup, A. Ohlhues, Kjær, T. Wesenberg, Madsen, K. Hougaard, Miskowiak, K., Petersen, P. Michael, and Høgh, P., Safety, Feasibility, and Potential Clinical Efficacy of 40 Hz Invisible Spectral Flicker versus Placebo in Patients with Mild-to-Moderate Alzheimer's Disease: A Randomized, Placebo-Controlled, Double-Blinded, Pilot Study., J Alzheimers Dis, vol. 92, no. 2, pp. 653-665, 2023.

Pages